Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma
2007 Standout
Actinomycotic brain abscess as the first clinical manifestation of hereditary hemorrhagic telangiectasia—case report and review of the literature
2012
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
2019 StandoutNobel
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
2018 Standout
Molecular imaging in drug development
2008 Standout
A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): A missing link within the spectrum of the idiopathic inflammatory myopathies
2006
The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease
2016
Chromosomal Aberration Patterns Differ in Subtypes of Primary Cutaneous B Cell Lymphomas
2004
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas
2004
Rituximab in Severe Pemphigus
2009
Cd30+ cutaneous lymphoproliferative disorders: The stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma
2003
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
New Treatment Guidelines for Sjögren's Disease
2016
Atopic dermatitis
2015 Standout
Ischemic optic neuropathy
2008 Standout
Trial of Tocilizumab in Giant-Cell Arteritis
2017 Standout
Role of AID in Tumorigenesis
2007 StandoutNobel
The Erythrocyte Sedimentation Rate Is Associated with the Development of Visual Complications in Biopsy-Proven Giant Cell Arteritis
2008
Immune mechanisms in medium and large-vessel vasculitis
2013
Stroke associated with giant cell arteritis: a population-based study
2014
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism
2016 Standout
Medium- and Large-Vessel Vasculitis
2003
Complications of Stevens–Johnson syndrome beyond the eye and skin
2015
Primary Cutaneous T-Cell–Rich B-Cell Lymphoma: Clinically Distinct from Its Nodal Counterpart?
2001
TFOS DEWS II pathophysiology report
2017 Standout
Molecular Cytogenetic Analysis of Chromosomal Breakpoints in the IGH, MYC, BCL6, and MALT1 Gene Loci in Primary Cutaneous B-cell Lymphomas
2004
The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study
2011 Standout
Risk factors for visual loss in an Italian population‐based cohort of patients with giant cell arteritis
2005
Gout
2016 Standout
Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance
2003
World Health Organization classification of hematopoietic and lymphoid tissues: Implications for dermatology
2003
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Toxic epidermal necrolysis
2013
Dimethyl Fumarate Modulation of Immune and Antioxidant Responses: Application to HIV Therapy
2013
Primary Cutaneous Diffuse Large B-cell Lymphoma
2003
Therapy of Cutaneous Lymphoma – Current Practice and Future Developments
2003
EORTC Cutaneous Lymphoma Task Force
2002
Advances in the understanding and treatment of systemic complications in Sjögren's syndrome
2014
The AID Dilemma
2012 StandoutNobel
Interaction of aldehydes derived from lipid peroxidation and membrane proteins
2013
Recent advances in the clinical management of giant cell arteritis and Takayasu arteritis
2016
Polymyositis and dermatomyositis
2003 Standout
Co‐expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases
2000
Cutaneous Dermatomyositis: An Updated Review of Treatment Options and Internal Associations
2013
119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands
2004 Standout
Giant Cell Arteritis: Epidemiology, Diagnosis, and Management
2010
Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity
2009
Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012
2013
Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy
2012
Rebleeding from ruptured intracranial aneurysms
1989
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Primary Cutaneous B-Cell Lymphoma Treated With Radiotherapy: A Comparison of the European Organization for Research and Treatment of Cancer and the WHO Classification Systems
2004
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Inflammatory Muscle Diseases
2015 Standout
The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study
2016
Actinomyces and Related Organisms in Human Infections
2015 Standout
Primary and secondary cutaneous CD30+lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment
2000
Giant Cell Arteritis versus Takayasu Arteritis: An Update
2020
Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling
2004
Skin Necrosis as a Predictive Factor for Neoplasia in Dermatomyositis
2010
SATB1 Defines a Subtype of Cutaneous CD30+ Lymphoproliferative Disorders Associated with a T-Helper 17 Cytokine Profile
2018
Role of Thrombocytosis in Diagnosis of Giant Cell Arteritis and Differentiation of arteritic from Non-Arteritic Anterior Ischemic Optic Neuropathy
2004
Speech can produce jet-like transport relevant to asymptomatic spreading\n of virus
2020
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
2012 Standout
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
CutaneousT ‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management
2015
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2008 Standout
Airborne transmission of respiratory viruses
2021 StandoutScience
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2007 Standout
Works of K.H. Ly being referenced
Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach
2011
Cerebral abscesses in hereditary haemorrhagic telangiectasia: A clinical and microbiological evaluation
2011
Interleukin-1 blockade in refractory giant cell arteritis
2013
Twelve-Year Analysis of Severe Cases of Drug Reaction With Eosinophilia and Systemic Symptoms
2009
Statistical Evaluation of Diagnostic and Prognostic Features of CD30+ Cutaneous Lymphoproliferative Disorders
1998
Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients
2016
Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients
2001
Giant Cell Arteritis–related Stroke: A Retrospective Multicenter Case-control Study
2017
Polymyositis and pemphigus vulgaris in a patient: Successful treatment with rituximab
2008
Immunological profiles determine neurological involvement in Sjögren's syndrome
2013
Ileal involvement in toxic epidermal necrolysis (Lyell syndrome)
1993
Pathogenesis of giant cell arteritis: More than just an inflammatory condition?
2010
Articular manifestations in primary Sjogren's syndrome: clinical significance and prognosis of 188 patients
2010
Topical corticosteroids in plaque psoriasis: a systematic review of efficacy and treatment modalities
2012
Routine vs Extensive Malignancy Search for Adult Dermatomyositis and Polymyositis
2002
Prognostic Factors in Primary Cutaneous Large B-Cell Lymphomas: A European Multicenter Study
2001
Familial aggregation in giant cell arteritis and polymyalgia rheumatica: a comprehensive literature review including 4 new families.
2010
SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany
2020
Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course.
2003
Assessment of diagnostic criteria between primary cutaneous anaplastic large-cell lymphoma and CD30-rich transformed mycosis fungoides; a study of 66 cases
2015
Saccular aneurysms, subarachnoid hemorrhage, and the timing of surgery.
1985